English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213610
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis

AuthorsAffandi, A.J.; Carvalheiro, T.; Ottria, A.; Broen, J.C.A.; Bossini-Castillo, L.; Tieland, R.G.; Bon, L.V.; Chouri, E.; Rossato, M.; Mertens, J.S.; Garcia, S.; Pandit, A.; De Kroon, L.M.G.; Christmann, R.B.; Martín, J.; Van Roon, J.A.G.; Radstake, T.R.D.J.; Marut, W.
KeywordsRUNX3
dendritic cells
fibrosis
inflammation
systemic sclerosis
Issue Date2019
PublisherBMJ Publishing Group
CitationAnnals of the Rheumatic Diseases (2019)
AbstractObjectives: Systemic sclerosis (SSc) is an autoimmune disease with unknown pathogenesis manifested by inflammation, vasculopathy and fibrosis in skin and internal organs. Type I interferon signature found in SSc propelled us to study plasmacytoid dendritic cells (pDCs) in this disease. We aimed to identify candidate pathways underlying pDC aberrancies in SSc and to validate its function on pDC biology. Methods: In total, 1193 patients with SSc were compared with 1387 healthy donors and 8 patients with localised scleroderma. PCR-based transcription factor profiling and methylation status analyses, single nucleotide polymorphism genotyping by sequencing and flow cytometry analysis were performed in pDCs isolated from the circulation of healthy controls or patients with SSc. pDCs were also cultured under hypoxia, inhibitors of methylation and hypoxia-inducible factors and runt-related transcription factor 3 (RUNX3) levels were determined. To study Runx3 function, Itgax-Cre:Runx3 mice were used in in vitro functional assay and bleomycin-induced SSc skin inflammation and fibrosis model. Results: Here, we show downregulation of transcription factor RUNX3 in SSc pDCs. A higher methylation status of the RUNX3 gene, which is associated with polymorphism rs6672420, correlates with lower RUNX3 expression and SSc susceptibility. Hypoxia is another factor that decreases RUNX3 level in pDC. Mouse pDCs deficient of Runx3 show enhanced maturation markers on CpG stimulation. In vivo, deletion of Runx3 in dendritic cell leads to spontaneous induction of skin fibrosis in untreated mice and increased severity of bleomycin-induced skin fibrosis. Conclusions: We show at least two pathways potentially causing low RUNX3 level in SSc pDCs, and we demonstrate the detrimental effect of loss of Runx3 in SSc model further underscoring the role of pDCs in this disease.
Publisher version (URL)http://dx.doi.org/10.1136/annrheumdis-2018-214991
URIhttp://hdl.handle.net/10261/213610
DOIhttp://dx.doi.org/10.1136/annrheumdis-2018-214991
Identifiersdoi: 10.1136/annrheumdis-2018-214991
issn: 0003-4967
e-issn: 1468-2060
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.